Your browser doesn't support javascript.
loading
Predictive factors of outcomes in patients with AL amyloidosis treated with daratumumab.
Szalat, Raphael E; Gustine, Joshua; Sloan, J Mark; Edwards, Camille V; Sanchorawala, Vaishali.
Afiliación
  • Szalat RE; Amyloidosis Center, Boston University School of Medicine and Section of Hematology and Oncology, Boston Medical Center, Boston, Massachusetts, USA.
  • Gustine J; Amyloidosis Center, Boston University School of Medicine and Section of Hematology and Oncology, Boston Medical Center, Boston, Massachusetts, USA.
  • Sloan JM; Amyloidosis Center, Boston University School of Medicine and Section of Hematology and Oncology, Boston Medical Center, Boston, Massachusetts, USA.
  • Edwards CV; Amyloidosis Center, Boston University School of Medicine and Section of Hematology and Oncology, Boston Medical Center, Boston, Massachusetts, USA.
  • Sanchorawala V; Amyloidosis Center, Boston University School of Medicine and Section of Hematology and Oncology, Boston Medical Center, Boston, Massachusetts, USA.
Am J Hematol ; 97(1): 79-89, 2022 01 01.
Article en En | MEDLINE | ID: mdl-34739735

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Amiloidosis de Cadenas Ligeras de las Inmunoglobulinas / Antineoplásicos Inmunológicos / Anticuerpos Monoclonales Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Amiloidosis de Cadenas Ligeras de las Inmunoglobulinas / Antineoplásicos Inmunológicos / Anticuerpos Monoclonales Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos